Evolocumab

CAS 1256937-27-5 1 FDA-DMF supplierBiologic

Overview

Evolocumab is a monoclonal antibody that works by inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9) to lower LDL cholesterol levels. It is prescribed to patients with certain genetic conditions leading to high cholesterol or those with atherosclerotic cardiovascular disease who require additional LDL lowering.

Therapeutic areas

Cardiovascular DiseasesHyperlipidemia

Related APIs

Atorvastatin
44 suppliers
Bosentan
40 suppliers
Ticagrelor
35 suppliers
Rosuvastatin
34 suppliers
Chlorthalidone
27 suppliers
Ranolazine
27 suppliers
Carvedilol
26 suppliers
Bempedoic Acid
17 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo